Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.15M Sell
51,138
-10,031
-16% -$1.16M 1.74% 30
2025
Q4
$6.44M Buy
61,169
+607
+1% +$57K 1.93% 22
2025
Q3
$5.08M Buy
60,562
+1,195
+2% +$98.4K 1.52% 29
2025
Q2
$4.7M Buy
+59,367
New +$4.72M 1.49% 34

Other funds holding MRK

BCWM LLC's MRK Position: Q1 2026 in Review

BCWM LLC reduced its Merck (MRK) stake by 16% in Q1 2026, selling an estimated $1.16M and leaving 51,138 shares worth $6.15M. The position accounts for 1.74% of the portfolio, ranked #30.

BCWM LLC first reported a position in MRK in Q2 2025 and has held it in 4 quarters since. The position peaked at $6.44M in Q4 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • BCWM LLC held 51,138 shares of Merck worth $6.15M as of Q1 2026.
  • BCWM LLC sold 10,031 Merck shares in Q1 2026, an estimated $1.16M.
  • Merck made up 1.74% of BCWM LLC's portfolio in Q1 2026, its #30 holding.
  • BCWM LLC first reported a position in Merck in Q2 2025 and has held it in 4 quarters since.
  • BCWM LLC's Merck position peaked at $6.44M in Q4 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on BCWM LLC's 13F filing for Q1 2026, filed 14 May 2026.